Food and Drug Administration

Transmissible Spongiform Encephalopathies Advisory Committee

October 25, 2001


Topic I: FDA Draft Guidance "Revised Preventive Measures to Reduce the Possible Risk of Transmission of CJD and vCJD by Blood and Blood Products"  Dorothy Scott,  MD, FDA   ppt     htm

Update: DHHS Meeting held on September 24, 2001, Stephen D Nightingale, MD, Office of Public Health and Science   pdf

Update: Anticipated implementation of New Donor Deferral Policies

Celso Bianco, MD, America's Blood Centers   pdf

Jacquelyn Fredrick, American Red Cross   pdf

Robert Jones, MD, New York Blood Center   pdf

G. Michael Fitzpatrick, PhD, Col, MS, Armed Service Blood Program, DoD   ppt   htm

Topic 2. Discussion of Amino Acid Sourcing and Production, and the Theoretical Risk of Transmission of the BSE Agent Through Their Use in Biopharmaceutical Products, Gerald Feldman, PhD, FDA   ppt   htm

Amino Acid Products, Gerard Richet, Degussa-Rexim   ppt   htm

Open Public Hearing

American Association of Blood Banks, Karen Shoos Lipton, JD   pdf